Transcriptome Studies on the Toxicity of Silica Nanoparticles by Hsu, Shih-Yi
University of South Florida 
Scholar Commons 
Graduate Theses and Dissertations Graduate School 
June 2020 
Transcriptome Studies on the Toxicity of Silica Nanoparticles 
Shih-Yi Hsu 
University of South Florida 
Follow this and additional works at: https://scholarcommons.usf.edu/etd 
 Part of the Medicinal Chemistry and Pharmaceutics Commons, and the Nanoscience and 
Nanotechnology Commons 
Scholar Commons Citation 
Hsu, Shih-Yi, "Transcriptome Studies on the Toxicity of Silica Nanoparticles" (2020). Graduate Theses and 
Dissertations. 
https://scholarcommons.usf.edu/etd/8228 
This Thesis is brought to you for free and open access by the Graduate School at Scholar Commons. It has been 
accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. 
For more information, please contact scholarcommons@usf.edu. 
 
 
 
 
 
Transcriptome Studies on the Toxicity of Silica Nanoparticles 
 
 
 
by 
 
 
 
Shih-Yi Hsu 
 
 
  
 
A thesis submitted in partial fulfillment 
of the requirements for the degree of 
Master of Science in Pharmaceutical Nanotechnology 
Taneja College of Pharmacy 
University of South Florida 
 
 
 
Major Professor: Feng Cheng, Ph.D. 
Vijaykumar Sutariya, M.Pharm., Ph.D., R.Ph. 
Alya Limayem, Ph.D. 
Sheeba Varghese Gupta, M.Pharm., Ph.D. 
 
 
Date of Approval: 
June 11, 2020 
 
 
 
Keywords: nanotoxicities, bioinformatics, gene expression, pathway, genomic database, 
cell lines 
 
Copyright © 2020, Shih-Yi Hsu 
 
 
 
 
 
 
Acknowledgment 
Dr. Feng Cheng always gives me directions when I am confused with the 
progression of this project. I learn so many useful tips from Dr. Daniel Denmark. I also 
have many thanks to Dr. Limayem, Dr. Sutariya, and Dr. Gupta for being my committee 
members, to my family for their encouragement to me, as well as to people behind the 
scene. It is so wonderful to do research in such a supportive environment.  
 
i 
 
 
 
Table of Content 
 
List of Tables ................................................................................................................... iii 
 
List of Figures .................................................................................................................. iv 
 
Abstract ........................................................................................................................... v 
 
Chapter 1: Introduction for toxicity of nanoparticle and toxicogenomics .......................... 1 
1.1 Nanoparticles .................................................................................................. 1  
1.2 Silica nanoparticles ......................................................................................... 2 
1.3 Toxicity of nanoparticles ................................................................................. 3 
1.4 Toxicogenomics .............................................................................................. 4 
 
Chapter 2: Silica nanoparticle effects on human heart epithelial cell .............................. 7 
2.1 Introduction ..................................................................................................... 7 
2.2 Methods and data set ..................................................................................... 7 
2.2.1 Gene Expression Omnibus database ............................................... 7 
2.2.2 Define groups ................................................................................... 7 
2.2.3 Refine the results of expressed gene ................................................ 8 
2.2.4 Generation of genetic pathways ....................................................... 9 
2.2.5 Computer hardware system and settings ........................................ 10 
2.3 Results.......................................................................................................... 10 
2.3.1 Differentially expressed genes ........................................................ 10 
2.3.2 Gene pathways and ontology analysis ............................................ 13 
  
Chapter 3: Silica nanoparticle effects on mouse macrophage ...................................... 18 
3.1 Introduction ................................................................................................... 18 
3.2 Data set ........................................................................................................ 18 
3.3 Results.......................................................................................................... 18 
3.3.1 Differentially expressed genes ........................................................ 18 
3.3.2 Gene pathways and ontology analysis ............................................ 21 
 
Chapter 4: Silica nanoparticle effects on A549 lung cancer cells .................................. 23 
4.1 Introduction ................................................................................................... 23 
4.2 Data set ........................................................................................................ 23 
4.3 Results.......................................................................................................... 23 
4.3.1 Differentially expressed genes ........................................................ 23 
4.3.2 Gene pathways and ontology analysis ............................................ 23 
 
ii 
 
Chapter 5: Possible pathways and mechanism of toxicity caused by silica 
nanoparticles ........................................................................................................... 26 
 
Chapter 6: Conclusion ................................................................................................... 30 
  
References .................................................................................................................... 31 
 
Appendix ....................................................................................................................... 37 
Abbreviation list .................................................................................................. 37 
 
  
iii 
 
 
 
List of Tables 
 
Table 1.   Association of gene number and cell survival................................................ 11                
  
Table 2.   Enriched Pathways in up-regulated genes in human sample ........................ 15 
 
Table 3.   TNF Pathways with up-regulated genes in human and mouse cells ............. 28  
iv 
 
 
 
List of Figures 
 
Figure 1.   Chemical structure of PAMAM ....................................................................... 8 
 
Figure 2.   Icon of the GEO database .............................................................................. 9 
 
Figure 3.   The association between the number of differentially expressed genes    
with cell survival ........................................................................................... 12 
 
Figure 4.   Gene regulated by silica nanoparticles ........................................................ 13 
 
Figure 5.   Enriched gene pathways in up-regulated genes .......................................... 14 
 
Figure 6.   Regulated genes by 10nm SNPs at low, medium and high concentration ... 19  
 
Figure 7.   Regulated genes by 500nm SNPs at low, medium and high 
concentration ............................................................................................... 20 
 
Figure 8.   The number of regulated genes by different sizes SNPs at low, 
medium and high concentration ................................................................... 21 
 
Figure 9.   Enriched gene pathways in up-regulated genes with both sized SNPs ........ 22 
 
Figure 10. Regulated genes by different sizes SNPs in A549 cells ............................... 24 
 
Figure 11. Enriched gene pathways in up-regulated genes in A549 cells ..................... 25 
 
Figure 12. TNF signaling pathway ................................................................................. 29 
  
v 
 
 
 
Abstract 
Nanotechnology enables more precise harmony in health condition via reducing the 
dosage amount, improving the delivery of hydrophobic drugs, more specific targeting to 
the cancerous sites, and so on. Nevertheless, issues regarding the toxicity of 
nanotechnology have begun to call for attention several decades later after the 
innovation of nanotechnology. Tools about risk management of nanotechnology have 
been developed, but  recently not much evidence recognizes the toxicity of 
nanoparticles (NPs) except for some animal studies, which demonstrated organ 
damage after the exposure to NPs. Toxicogenomic approach refers to the method 
utilizing gene expression to evaluate the chemical toxicity. Databases as Gene 
Expression Omnibus and Database for Annotation, Visualization, and Integrated 
Discovery are useful platform to provide information about genomic and genetic 
pathway. After comparing groups at 4 hours and 24 hours, our study reveals the toxicity 
of silicon dioxide (SiO2) NPs to human aortic endothelial cells (HAECs) is affected by 
their morphology, and via regulation of different amounts of genes. Cytotoxicity is also 
related to materials as SiO2 and poly-amido-amine. More analyses with SiO2 NPs 
cultured with mouse macrophages and lung cancer cells, A549 cells, indicates the size 
as the attribute of silica nanotoxicity. Smaller SiO2 particles appear to be more toxic in 
medium concentration. Among all these three cells (HAECs, mouse macrophages, and 
A549 cells), tumor necrosis factor (TNF) signaling pathway is the most highly up-
regulated pathway. Therefore, the expression of TNF signaling pathway highlights the 
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sub cellular mechanism of toxicity resulted from silica NPs regardless of the morphology 
or the size of the particles, and the cell types.   
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Chapter 1: Introduction for toxicity of nanoparticle and toxicogenomics 
1.1 Nanoparticles 
The concept of 'nano' was developed more than half a century ago. 
Nanoparticles (NPs) demonstrate new physicochemical properties compared to their 
bulk materials. A nanometer is one billionth of a meter and is a useful unit of measure in 
many fields, such as diagnostic devices and therapeutic drugs in the medical field 
(Bhushan, B, 2017.; Kumar et al, 2013; Jain, K. K. 2017).  
Not only does nanotechnology provide an alternative way to enhance drug 
delivery, the novel traits of NPs also provide useful ways as treatments (Patra et al., 
2018). By applying NPs in drug delivery, the bioavailability of hydrophobic compounds is 
possible to be improved, and more precise delivery to diseased sites is able to be 
achieved with active targeting or stimulus related targeting. An innovative scope at the 
molecular level is built with nanomedicine in both diagnostic and therapeutic field (Kim, 
Rutka, & Chan, 2010). Currently, FDA has approved several drugs with nanotechnology 
such as PEGylations or liposomes (Bobo, Robinson, Islam, Thurecht, & Corrie, 2016). 
The pegylated products have longer circulation time and the drugs delivered by 
liposomes appear to have less toxicity (Alconcel, Baas, & Maynard, 2011; James et al., 
1994). Due to the advantage of surface area to volume ratio, less dosage is required for 
the same therapeutic effects as nanocrystals (Jens-Uwe, 2008). The 
superparamagnetic character of iron oxide NPs is applied in diagnostic imaging tool 
(Bashir, Bhatti, Marin, & Nelson, 2015). A number of NPs have been explored and 
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investigated, so a future with less detrimental effects on healthy tissues while treating 
diseases will come. 
1.2 Silica nanoparticles  
The oxidized form of silicon, silica or silica dioxide (SiO2), is the most abundant 
compound on earth. Several strengths of using silica nanoparticles (SNPs) are their low 
cost, convenience of scale-up, ability to be modified with surface groups, and their 
biocompatibility (Nafisi & Maibach, 2015). Fumed or pyrogenic silica has been used in 
cosmetics as solvable powder to prevent pigments from aggregation. It also soothes 
greasy skin and provides ultraviolet (UV) protection. SNPs also enhance the penetration 
of drugs into the dermis layer of the skin (Nafisi & Maibach, 2015). Moreover, they are 
used as additive agents in powder to prevent mass formation in food industry 
(Athinarayanan, Periasamy, Alsaif, Al-Warthan, & Alshatwi, 2014). 
One method to make SNPs was using lysine as catalyst. Hydrolysis and water 
separation were involved in the process (Pirutchada et al., 2019). With adding 
surfactant as templates, porous SNPs were created (Patil, Verma, Patil, Naik, & 
Narkhede, 2019).  
Mesoporous silica nanoparticles (MSNPs) were designed for cancer therapy 
because they were capable of loading drugs in the tunable pores and being delivered to 
the tumor sites. Adding organic part to the mesoporous silica platform improved their 
degradation (Guimaraes, Rodrigues, Moreira, & Correia, 2020). For example, loaded 
with 5-fluorouracil and NAD(P)H:quinone oxidoreductase 1 inhibitor, MSNPs coated 
with lipid bilayers reduced head and neck squamous cell carcinoma  volume in mice 
model in addition to increasing cancer cell death (Chen et al., 2019). MSNPs loaded 
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with aceclofenac were demonstrated in vitro with the increasing half-life of aceclofenac 
(Patil et al., 2019). The delivery route of the drug might also be changed by MSNPs, 
such as oral insulin (Juère, Caillard, Marko, Del Favero, & Kleitz, 2020). Beside the 
advantage of carrying drugs with the pores, SNPs were easy to be manipulated with the 
surface morphology. By modifying the MSNPs with aptamer, Sgc8, doxorubicin was 
more selectively delivered to leukemia cells (Yang et al., 2019). With modification of the 
surface molecular group, MSNPs could release the loading drugs in acidic environment, 
or when they were stimulated by UV light at 365 nm wave length (Wang, Wang, Wang, 
Jiang, & Fu, 2019). Another research showed 12 nm SNPs resulted in the death of 
astrocytoma U87 cells, one kind of human brain tumor cells, when the concentration is 
above 25  g/ml (Lai et al, 2010). Besides, in micro-electromechanical systems, SiO2 
film is a common part of cantilever fabrication (Bhatt & Chandra, 2007). When SNPs 
were doped with quantum dots and were further conjugated with antibodies, they could 
be used as fluorescent dye to visualize leukemia cells (Bottini et al., 2007). A better 
image quality derived when SNPs were doped with dyes and contained a gold core 
(Galanzha et al., 2017). Together, these evidences revealed the potential popularity of 
SNPs in the drug delivery and the diagnosis, although a gap between efficacy and 
safety may need to be overcome. 
1.3 Toxicity of nanoparticles 
In addition to the low delivery rate of NPs to tumors (Wilhelm et al, 2016), 
another hurdle is some evidence with toxicity in animal studies and in vitro studies, thus 
the term, nanotoxicity (Donaldson et al, 2004; Arora et al, 2011). The nanotoxicity 
describes the debilitating effects of nanoparticles on living systems as well as ecological 
4 
 
systems (Aggarwal et al, 2009). Human bodies are exposed to NPs through ocular, 
inhalational, dermal contact, oral and other numerous routes (Oberdörster et al, 2005). 
Knowledge of adverse effects about NPs to vascular endothelial cells is crucial, 
while intravenous drug delivery is an effective way to treat systemic diseases or 
invasively diagnostic devices are adopted to detect blood components. Iron oxide NPs 
as imaging NPs induced inflammation response and oxidative stress to human aortic 
endothelial cells and umbilical endothelial cells as well as pulmonary fibrosis in animal 
model, despite no obvious toxicity in clinic for iron oxide NPs (Li et al. 2014, Zhu et al. 
2010, 2011). In addition, CdTe is found to have dose-dependent cytotoxicity in human 
umbilical vein endothelial cells (Yan et al, 2011). Hemolytic toxicity of human red blood 
cells is found with larger size of modified or unmodified graphene oxide above 300 nm 
(Kiew et al, 2016; Liao et al, 2011). TiO2 nanobelts (TiO2-NB) are considered more toxic 
to THP-1 cells than multi-walled carbon nanotubes since evidence shows TiO2-NB 
regulates gene pathways with inflammation, apoptosis and cell cycle arrest (Tilton et al, 
2013). The shape of SiO2 NPs as well as functional groups of poly(amido amine) 
(PAMAM) dendrimers have different levels of toxicity on human aortic endothelial cells. 
Spherical shape SiO2 NPs are toxic at lower concentration than worm shape SiO2. 
Carboxyl ended dendrimers seem to have less toxic effect than amine ended 
dendrimers (Moos et al, 2013).  
1.4 Toxicogenomics  
As early as in 1980s, scientists began to investigate the relationship between 
genes and toxicity. The niridazol, an agent against schistosomiasis, was researched for 
the relationship between its neurotoxicity and the Ah locus of mice (Blumer, Simpson, 
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Lucas, & Webster, 1980). Stemmed from the human genome project, plates coated with 
genetic materials as DNA arrays were being used to test the chemical toxicity, an 
approach named as a toxicogenomic model. Advocated by Lovett (2000), if this 
approach could overcome the puzzles between untested chemicals and actual 
outcomes such as real illness, toxicogenomic models might save the cost of 
experimental animals and detect chronic diseases as early as possible (Lovett, 2000).  
Paved with this concept, big genomic data used to predict liver injury such as 
fibrotic and necrotic pathology with drug dosage in humans and mice was developed in 
the following years (Kohonen et al., 2017). In addition, it is possible to track the 
molecular pathways related with hepatitis B virus (HBV) in hepatocellular carcinoma 
(HCC). With the amount of 113 overlapping genes derived from two datasets, AMPK 
signaling pathway and responses to cadmium ions were likely to be involved in HBV 
related HCC (Li et al., 2020).  
Toxicogenomic models can also be applied to assess nanotoxicities. Several 
databases were built despite scarce research in nanotoxicities. The NanoSolveIT 
project is an example, aimed to integrate these databases to provide a platform to 
predict adverse effects of nanomaterials based on their infrastructure, gene expression 
data, and various endpoints (Afantitis et al., 2020). 
Through studying genomic expression of human cell lines after exposure to NPs, 
more understanding in the mechanism of toxicity caused by NPs is able to be revealed 
(Moos et al., 2013). In this project, we analyzed public transcriptome data on the toxicity 
of two drug delivery nanoplatforms for primary human aortic endothelial cells, as well as 
the toxicity of silica NPs on mice macrophages and lung cancer cells. The identified 
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genes and gene pathways may assist the risk management of these nanoplatforms. 
More specification of the affected genes owns the potential to assist the pharmaceutical 
industry in designing dosage and morphology of coming nano-components. 
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Chapter 2: Silica nanoparticle effects on human heart epithelial cell 
2.1 Introduction  
In this chapter, the transcriptional responses of primary HAECs to SNPs and 
PAMAM dendrimers were identified. We tried to see the gene changes of endothelial 
cells caused by these drug delivery nanoplatforms. 
2.2 Methods and data set 
The study was based on a National Center for Biotechnology Information’s 
(NCBI) Gene Expression Omnibus (GEO) data set, GSE35142. In this data set, the 
effects on gene expression of HAECs by two different shapes of SNPs (sphere and 
worm) and carboxyl (COOH) PAMAM group and the amine (NH2) PAMAM were 
investigated. The chemical structure of PAMAM was shown in Figure 1. 
2.2.1 Gene Expression Omnibus database 
Gene expression data was analyzed with the NCBI’s GEO database (Edgar & 
Barrett, 2006). After searching with the keyword as “human aortic endothelial cells, 
silicon dioxide,” further information was retrieved with clicking the “Analyze with 
GEO2R” tab (Figure 2). The website address was as follows: 
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE35142. 
2.2.2 Define groups 
The SiO2 and PAMAM groups were defined in NCBI GEO2R analyzer. Groups of 
the same material either SiO2 or the dendrimer were compared between different time 
period as 4 hr and 24 hr. Groups with various materials modified differently were also 
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 (a) core of PAMAM              (b) G2-NH2 PAMAM 
compared within the same time period, 4 hr and 24 hr respectively. For example, the 
group name was entered as “SiO2 worm 4hr” after clicking the tab “define groups” and 
then select the following items with “200nm SiO2 worm 4hr incubation 100  g/ml.” Next, 
another group named as “SiO2 sphere 4hr” was created and filled with “200nm SiO2 
spheres 4hr incubation 73.38  g/ml.” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Chemical structure of PAMAM 
Note. (a) The core of PAMAM was similar to ethane in the central with hydrogen atoms replaced 
by tertiary amine nitrogen atoms. The surface layers were four primary amide groups. In other 
words, ethylene diamine was used as a core initiator. (b) Dendrimers were synthesized with 
divergent or convergent process. The nitrogen in the amide groups acted as nitrogen in 
ethylene diamine and this forms one generation. Once the amide group was replaced by 
carboxyl group, this forms a half generation.   
  
2.2.3 Refine the results of expressed gene 
During this process, the actions were to hit the “TOP250” tab and click the “Save 
all results” link to open a new window. The data of gene lists was saved as text files 
(*.txt) after the processing is done. For statistical significance, the collected gene lists 
were organized by eliminating data with adjusted p value over 0.05. The up and down 
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regulated genes were further adjusted in accordance with log (Fold Change), which was 
labeled as log FC, more or less than 1 with Microsoft Excel software. The value of fold 
change (FC) as 1.25 was also considered. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Icon of the GEO database 
Note. The icon was from the websites of Gene Expression Omnibus. In the figure, the tab for 
analyzing at the bottom of the website page was shown below. 
 
2.2.4 Generation of genetic pathways 
The refined gene list was entered into the Database for Annotation, Visualization 
and Integrated Discovery (DAVID) (https://david.ncifcrf.gov) to generate Kyoto 
Encyclopedia of Genes and Genomes (KEGG) pathways (Dennis et al., 2003). The 
gene list was analyzed through functional annotation domain and under official gene 
symbol. Homo sapiens was designated as our species. The species was changed in 
mouse model. 
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2.2.5 Computer hardware system and settings  
The databases were run by Dell OptiPlex 3060 desktop computer core and Mac. 
The operating systems include Windows 10 developed by Microsoft Corporation and the 
search engine is Google Chrome.  
2.3 Results 
2.3.1 Differentially expressed genes 
Four materials, including worm shaped (100  g/ml) and spherical shaped (73.38 
 g/ml) SiO2 NPs, sizing around 200nm, COOH-PAMAM and NH2-PAMAM dendrimer 
were analyzed. The gene expression level difference of each material between 4 hr and 
24 hr were compared. The survivals of HAECs cells cultured with these 4 materials 
were also obtained. 
In toxicogenomics, the number of differentially expressed genes was a good 
measurement to evaluate the effects of treatment on a biological system. In our studies, 
we found there was a strong association between the number of differentially expressed 
genes and cell viability. In the HAECs data set, cell survival and transcriptome profiles 
of the endothelial cells were observed after 4 hours and 24 hours with conditions when 
cells were transfected with NPs of various morphologies and compositions. For 
instance, the quantities of regulated genes by spherical SNPs were analyzed between 4 
and 24 hours.  
As shown in Table 1, after 24 hours, there was a 57% (from 100% to 43%) 
decline in cell population for cells treated with SiO2 sphere shape NPs at a 
concentration of 100  g/ml. Between 4 hours and 24 hours post-transfection, 4411 
genes were found to be regulated at adjusted p-value < 0.05 and at least 1.25 fold 
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change. Transfection with worm formed SiO2 NPs resulted in a 19% (decreasing from 
100% to 81%) cell mortality rate and 368 differentially regulated genes after 24 hrs. 
Transfection with either the COOH-PAMAM nano construct or the NH2-PAMAM nano 
construct resulted in no cell mortality. A total of 2 and 15 differentially expressed genes 
were found for NH2-PAMAM and COOH-PAMAM material by comparing transcriptome 
of 4 hours with 24 hours.  
 
Table 1. Association of gene number and cell survival 
 
Nano_Construct Concentration Cell Survivor% 
#Regulated genes 
(4hr vs 24hr) 
SiO2_Worm 100  g/ml 81 368 
SiO2_Sphere 73  g/ml 43 4426 
G3.5-COOH_PAMAM 0.5  M 103 15 
G4-NH2_PAMAM 0.5  M 100 2 
 
Note. The regulated gene number is composed of both up and down regulated genes. The gene 
number are values after comparing 24 hr group with 4 hr group of different nano constructs, and 
the results with blank gene identity are eliminated.    
 
The linear relationship between the number of differentially expressed genes and 
the percentage of cell survival was shown in the Figure 3; there was a positive 
correlation between the cytotoxicity of the NPs and the number of differentially 
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expressed genes, of which a greater cell mortality rate was associated with a higher 
number of dysregulated genes. Since no cytotoxicity was observed with PAMAM 
groups, we defined a control group with all PAMAM materials. The control group was 
compared with worm and sphere shaped SNPs selected in one group.  
 
 
Figure 3. The association between the number of differentially expressed genes with 
cell survival 
Note. The correlation was noted in the figure. Generally, the more the differential expressed 
genes were affected, the less survival chance the cells had. Spherical SNPs affected more 
genes than worm shaped SNPs, so the percentage of HAECs cultured with the spherical SNPs 
was less. Moreover, the figure showed SNPs were more toxic than PAMAM.  
 
The levels of the differentially regulated genes as a result of comparing SNPs 
with PAMAM were demonstrated in Figure 4. More genes were up regulated by the 
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group of SNPs than the number of genes down regulated when SNPs was compared 
with PAMAM. 
 
Figure 4. Gene regulated by silica nanoparticles 
Note. The genes are compared by using PAMAM as the control group. The red spots indicated 
the up regulated genes, so do the green spots. There are 2031 up-regulated and 1662 down-
regulated genes for silica material comparing with PAMAM.  
  
2.3.2 Gene pathways and ontology analysis 
The genetic pathways in Figure 5 were listed according to the level of fold 
change. Among these pathways, TNF signaling pathways were the most overly 
expressed one when comparing SNPs with PAMAM as described in the previous 
section. More details with the genes involved in the genetic pathways were given in 
Table 2. 
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Figure 5. Enriched gene pathways in up-regulated genes 
Note. TNF signaling pathway has the most statistical significance. These pathways are derived 
from the gene list by comparing silica NPs with PAMAM. 
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Table 2. Enriched Pathways in up-regulated genes in human sample  
 
Term Count PValue Genes 
Fold 
Enrichment FDR (%) 
hsa04668:TNF 
signaling pathway 29 5.13E-11 
TRAF1, CSF2, TNF, CCL2, 
PTGS2, CXCL3, CXCL2, 
NFKBIA, NFKB1, ATF2, 
VCAM1, LIF, FOS, CCL20, 
MAP3K8, BCL3, IL1B, 
ICAM1, SOCS3, MAP2K3, 
CREB1, MAPK11, CREB5, 
BIRC3, JUNB, RPS6KA5, 
JUN, TNFAIP3, SELE 4.27 6.68E-08 
hsa04010:MAPK 
signaling pathway 40 1.46E-07 
FGF5, TNF, DUSP10, 
NFKB1, HSPA1A, 
CACNB3, NFKB2, FGF12, 
ATF2, FOS, BDNF, RAC3, 
ELK4, MAP3K1, MAPT, 
SOS1, MAP3K8, DUSP16, 
RASGRP2, IL1B, IL1A, 
NFATC1, MAP2K5, 
LAMTOR3, MAP2K3, 
RELB, NR4A1, MAPK11, 
DDIT3, CDC25B, MAP4K3, 
RPS6KA5, DUSP5, 
RPS6KA6, DUSP2, 
DUSP1, RPS6KA2, JUN, 
GADD45B, MAP3K11 2.49 1.90E-04 
hsa05166:HTLV-I 
infection 39 4.66E-07 
CSF2, CRTC2, NRP1, TNF, 
CREM, ADCY6, NFKBIA, 
NFKB1, NFYB, ITGB2, 
NFKB2, CANX, ATF1, 
ATF2, VCAM1, FOS, ELK4, 
MAP3K1, NFATC2, TBPL1, 
NFATC1, FZD9, EGR1, 
ZFP36, ICAM1, KAT2B, 
EGR2, SLC25A6, CREB1, 
RELB, POLB, RB1, FZD5, 
DVL1, CDKN1A, ATF3, 
ETS1, JUN, WNT9A 2.42 6.06E-04 
 
Note. Details of the genes involved in different pathways up regulated by SNPs. The gene 
abbreviations, the count of genes in each pathway, p-values, adjusted p-values (FDR), and the 
value of logarithmic function with pathway fold change (fold enrichment) were listed in the table. 
16 
 
 
Table 2. (Continued) 
 
hsa05323:Rheumatoid 
arthritis 17 1.07E-04 
ICAM1, CSF2, TNF, CCL2, 
TLR2, CXCL8, ACP5, 
ITGB2, ATP6V1B2, FOS, 
CCL20, JUN, ATP6V1E1, 
TEK, IL1B, IL1A, CD28 3.04 0.14 
hsa05134:Legionellosis 13 1.08E-04 
EEF1A1, TNF, CXCL3, 
CXCL2, TLR2, CXCL8, 
NFKBIA, EEF1G, IL1B, 
NFKB1, ITGB2, HSPA1A, 
NFKB2 3.79 0.14 
hsa05202:Transcriptional 
misregulation in cancer 25 1.23E-04 
CCNT2, TRAF1, BMI1, 
CEBPA, NFKBIZ, CSF2, 
RXRB, RXRA, MET, 
CXCL8, NFKB1, SIX4, 
DDIT3, ATF1, MLF1, 
CDKN1A, CDKN1B, 
TAF15, REL, ELK4, PER2, 
MDM2, RARA, JMJD1C, 
KLF3 2.36 0.16 
hsa04380:Osteoclast 
differentiation 21 1.96E-04 
TNF, FOSL2, SOCS3, 
CREB1, RELB, NFKBIA, 
ACP5, NFKB1, MAPK11, 
NFKB2, FOSB, STAT1, 
JUNB, CYLD, FOS, 
SQSTM1, JUN, IL1B, 
NFATC2, IL1A, NFATC1 2.52 0.26 
hsa05200:Pathways in 
cancer 44 2.54E-04 
TRAF1, FGF5, PTGS2, 
PGF, ADCY6, CXCL8, 
NFKBIA, KITLG, NFKB1, 
NFKB2, FGF12, ITGB1, 
GLI1, FOS, RAC3, SOS1, 
RASGRP2, RALB, NKX3-1, 
RARA, TRAF4, FZD9, 
CEBPA, RXRB, RXRA, 
MET, RB1, FZD5, STAT1, 
BIRC3, DAPK3, RALGDS, 
DVL1, CDKN1A, CDKN1B, 
PLCG1, GNAQ, ETS1, 
JUN, RASSF1, MDM2, 
LAMC2, GNAS, WNT9A 1.76 0.33 
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Table 2. (Continued) 
 
hsa05161:Hepatitis B 22 2.90E-04 
EGR3, TNF, EGR2, 
CREB1, DDB1, TLR2, 
CXCL8, NFKBIA, NFKB1, 
CREB5, RB1, STAT1, 
ATF2, STAT6, FOS, 
CDKN1A, CDKN1B, JUN, 
MAP3K1, TICAM1, 
NFATC2, NFATC1 2.39 0.38 
hsa04064:NF-kappa B 
signaling pathway 16 3.23E-04 
TRAF1, ICAM1, TNF, 
PTGS2, RELB, CXCL8, 
NFKBIA, UBE2I, NFKB1, 
NFKB2, BIRC3, VCAM1, 
PLCG1, TICAM1, IL1B, 
TNFAIP3 2.89 0.42 
hsa05140:Leishmaniasis 14 4.39E-04 
TNF, PTGS2, NFKBIB, 
TLR2, NFKBIA, NFKB1, 
ITGB2, MAPK11, STAT1, 
ITGB1, FOS, JUN, IL1B, 
IL1A 3.10 0.57 
hsa04722:Neurotrophin 
signaling pathway 19 5.05E-04 
IRAK2, NFKBIE, NFKBIB, 
NFKBIA, NFKB1, 
MAPK11, RPS6KA5, 
RPS6KA6, BDNF, PLCG1, 
RPS6KA2, JUN, MAP3K1, 
SOS1, GAB1, PSEN2, 
CAMK2D, RIPK2, 
MAP2K5 2.49 0.66 
hsa04621:NOD-like 
receptor signaling 
pathway 12 6.46E-04 
TNF, CCL2, NFKBIB, 
CXCL2, CXCL8, RIPK2, 
NFKBIA, IL1B, NFKB1, 
MAPK11, BIRC3, 
TNFAIP3 3.37 0.84 
hsa05144:Malaria 11 8.27E-04 
VCAM1, ICAM1, TNF, 
CD36, CCL2, MET, TLR2, 
CXCL8, IL1B, ITGB2, 
SELE 3.53 1.07 
hsa05168:Herpes 
simplex infection 23 0.0026 
TRAF1, HMGN1, 
GLTSCR2, TNF, CCL2, 
SOCS3, NFKBIB, TLR2, 
NFKBIA, NFKB1, HCFC2, 
CDC34, STAT1, FOS, 
TAF5L, GTF2I, 
GTF2IRD1, JUN, TICAM1, 
PER2, IL1B, EIF2AK3, 
TBPL1 1.98 3.40 
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Chapter 3: Silica nanoparticle effects on mouse macrophage 
3.1 Introduction  
In this chapter, the gene expression changes of RAW 264.7 mouse macrophage 
cells regulated by two different sizes of amorphous SNPs (10 nm and 500 nm) at three 
different doses were identified. These three doses were labeled as low, medium, and 
high concentration. 
3.2 Data set 
The study described in this chapter was based on a NCBI GEO data set, 
GSE13005. In this data set, the effects on gene expression of RAW 264.7 mouse 
macrophage cells by 10 nm silica  at 5 (low), 20 (medium), or 50 (high)  g/ml for 2 
hours, as well as 500 nm silica at 250 (low), 500 (medium), or 1000 (high)  g/ml, were 
investigated. 
3.3 Results  
3.3.1 Differentially expressed genes 
The results of the differentially expressed genes with 10 nm and 500 nm SNPs 
were shown in Figure 6 and Figure 7 respectively. The colored spots, as green and red, 
represented the results with statistical significance of adjust p value (q value) less than 
0.05 and the Fold Change more or less than 1.25. The results without statistically 
significance were shown as black spots. At high dosage, more than 300 genes were 
regulated by both 10 nm and 500 nm SNPs. On the contrary, 10 nm particles were able 
to cause more gene changes than 500 nm NPs at medium dosage (Figure 8). 
19 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Regulated genes by 10nm SNPs at low, medium and high concentration   
Note. More differentially expressed genes were noted when the concentration became higher. 
Nevertheless, most genes (182) were up regulated with the medium concentration. The q value 
here was defined as adjust p value. 
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Figure 7. Regulated genes by 500nm SNPs at low, medium and high concentration 
Note. Higher concentration was related to more differentially expressed genes.  
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3.3.2 Gene pathways and ontology analysis 
Some enriched KEGG pathways with FDR value less than 0.05 were identified in 
up-regulated genes by NPs (Figure 8). Other than the medium concentration, 500 nm 
SNPs regulated more gene pathways than 10 nm SNPs at high concentration for 2 
hours. TNF signaling pathway (mmu04668) was the top pathway for both materials. 
Other common gene pathways regulated by these two sized NPs included MAPK 
signaling pathway, HTLV-I infection, cytokine-cytokine receptor interactions and Chagas 
disease. There was no enriched gene pathway shown in genes down regulated by 10 
nm or 500 nm SNPs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. The number of regulated genes by different sizes SNPs at low, medium and 
high concentration 
Note. 10 nm SNPs regulated more genes in medium concentration than 500 nm SNPs. More 
genes were affected when the concentration became higher. 
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Figure 9. Enriched gene pathways in up-regulated genes with both sized SNPs 
Note. TNF signaling pathway was up-regulated in both 10 nm and 500 nm groups. Genetic 
pathways of low and medium concentration were not shown. 
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Chapter 4: Silica nanoparticle effects on A549 lung cancer cells 
4.1 Introduction  
In this chapter, the gene expression changes of A549 lung cell lines regulated by 
two different sizes of SNPs (9 nm and 18 nm of diameter) were identified. 
4.2 Data set 
The study was based on a NCBI GEO data set, GSE53700. In this data set, the 
effects on gene expression of A549 lung cancer cells by two different sizes of SNPs (9 
nm and 18 nm of diameter) were investigated.  
4.3 Results 
4.3.1 Differentially expressed genes 
In the group with 9 nm SNPs, 910 genes were up-regulated and 340 genes were 
down-regulated. On the other hand, no differentially expressed genes were found in the 
group with 18 nm SNPs (Figure 10). The genes that were expressed twice more were 
analyzed with fold change as 2 and log (Fold Change) as 1.  
4.3.2 Gene pathways and ontology analysis 
More than 20 KEGG pathways were found in A549 lung cancer cell lines after 3 
hour exposure to 9 nm SNPs as shown in Figure 11. Among them, 18 KEGG pathways 
with Benjamini value less than 0.05 reached statistical significance.  These pathways 
are TNF signaling pathway, pathways in cancer, rheumatoid arthritis, transcriptional 
regulation in cancer, cytokine-cytokine-receptor interaction, TGF-beta signaling 
pathway, hematopoietic cell lineage, MAPK signaling pathway, signaling pathways 
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regulating pluripotency of stem cells, proteoglycans in cancer, NF-kappa B signaling 
pathway, HTLV-I infection, amoebiasis, Fc epsilon RI signaling pathway, NOD-like 
receptor signaling pathway and so on. TNF signaling pathway again appears in the list 
as the most significant regulatory pathway of SNPs. 
 
 
 
 
 
 
 
 
 
 
Figure 10. Regulated genes by different sizes SNPs in A549 cells 
Note. More genes were regulated in 9 nm group than 18 nm group. No genes were found 
regulated in the 18 nm group. The q value here was equal to adjust p value. 
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Figure 11. Enriched gene pathways in up-regulated genes in A549 cells  
Note. TNF signaling pathway was up-regulated the most by 9 nm SNPs with A549 cells as 
noted in the figure. No down regulated gene pathways were found. 
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Chapter 5: Possible pathways and mechanism of toxicity caused by silica 
nanoparticles 
TNF signaling pathway is a crucial way in regulating cell survival and death 
(Figure 11). Tumor necrosis factor (TNF) is a term coined by researcher as a serum 
factor that results in tumor regression. Shrinkage of tumor size and hemorrhagic 
necrosis are found after injection of lipopolysaccharide and BCG in a mouse model 
(Old, 1985).  
Two pathways with TNF-R1 and TNF R2 receptors are found currently, and there 
are two molecules, TNF alpha and TNF beta. More studies are done on TNF-R1 and 
TNA alpha.  Multiprotein signaling complex is formed during the process TNF signaling 
pathway. A variety of human diseases are related to this pathway, and it is the target of 
drug in immune disease such as rheumatoid arthritis. After extracellular domain of TNF-
R1 binds to TNF, a homotrimer of 157 amino acid subunits, TNF-R1’s intracellular 
domain (ICD) is revealed by separating from silencer of death domains (SODD) (Chen 
& Goeddel, 2002). ICD then binds to adaptor protein, TNF receptor-associated death 
domain (TRADD), and recruits additional adaptor proteins: TNF-R-associated factor 2 
(TRAF2), receptor-interacting protein (RIP), and Fas-associated death domain (FADD). 
The recruiting of Caspase-8 following FADD initiates a protease cascade for apoptosis. 
Other parts of the TNF and TNF-R1 signaling pathway involve various activations of 
enzymes result in anti-apoptosis or NFκB activation (Chen & Goeddel, 2002). In 
endothelial cells, TNF induces cell death and a procoagulation state. However, studies 
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show TNF-R2 in favor of cell apoptosis rather than TNF-R1 pathway, which reduces cell 
death (Nawroth & Stern, 1987; Okada et al, 2001). 
TNF alpha is a soluble polypeptide factor, or a cytokine, that serves as crosstalk 
between cells. It is composed of 20 proteins from the 18 genes located on the position 
of chromosome 7p21. It is produced by many cells including active B and T cells, mast 
cells, macrophages and monocytes, etcetera (Weinberg & Buchholz, 2006). The major 
source of TNF alpha is from activated macrophages. In addition to effects on antiviral 
activities, cellular metabolism, growth regulation of cells, coagulation processes, and 
insulin response, TNF alpha can trigger series of inflammatory processes, favoring 
antimicrobial response with inflammatory CD4 T cells (Th1) than atopic or allergic 
response with helper CD4 T cells (Th2). In endothelial cells, it aggravates vascular 
leakage and recruits lymphocytes. It also activates macrophages, increasing nitric oxide 
production (Weinberg & Buchholz, 2006). Therefore, some drugs focus on TNF alpha 
as the target to treat the disease. Other than TNF-alpha, which is mainly related to 
chronic systemic inflammatory response, TNF-beta is secreted by T cells and enhances 
phagocytic function of neutrophil and macrophages as well as cytotoxicity on tumor cells 
(Weinberg & Buchholz, 2006). 
Several studies use TNF alpha to evaluate the effect like oxidative stress by 
SNPs on cells. Silica nanoparticles around 10 nm were found to induce TNF alpha in 3D 
alveolar model as well as interleukin-1 in a concentration dependent manner (Skuland 
et al., 2020). Moreover, spherical SNPs between 10 and 50 nm induced TNF alpha 
mRNA expression in human lung fibroblast cells by quantitative RT-PCR 
(Athinarayanan, Periasamy, Alsaif, Al-Warthan, & Alshatwi, 2014). Another study with 
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human lung fibroblast cells showed silica in nano form had more TNF alpha expression 
than their micro form with western blotting, indicating more toxicity in nano form 
(Ahmad, Khan, Patil, & Chauhan, 2012). This result was similar to the result with 3D 
alveolar model. TNF alpha was not specific to SNPs. Different nanomaterials could 
induce TNF alpha rather than SNPs in human monocytes (Ainslie et al., 2009), and 
SNPs induced other pathways, too. One major component of silymarin, silibinin, was 
found to reduce the TNF alpha expression due to SNPs as wells as mitogen-activated 
protein kinase and thioredoxin-interacting protein (Lim et al., 2020). These evidences 
are consistent with our study that silica nanoparticles regulate cell toxicity through TNF 
signaling pathway. Moreover, common genes are found in human and mouse model of 
TNF signaling pathway as shown in Table 3. 
  
Table 3. TNF Pathways with up-regulated genes in human and mouse cells 
  
Term Count PValue Genes 
Fold 
Enrichment FDR (%) 
hsa04668:TNF 
signaling pathway 29 5.13E-11 
TRAF1, CSF2, TNF, CCL2, 
PTGS2, CXCL3, CXCL2, 
NFKBIA, NFKB1, ATF2, 
VCAM1, LIF, FOS, CCL20, 
MAP3K8, BCL3, IL1B, 
ICAM1, SOCS3, MAP2K3, 
CREB1, MAPK11, CREB5, 
BIRC3, JUNB, RPS6KA5, 
JUN, TNFAIP3, SELE 4.27 6.68E-08 
mmu04668:TNF 
signaling pathway 11 7.58E-09 
LIF, CFLAR, FOS, CCL2, 
TNF, PTGS2, JUN, CSF1, 
CXCL2, EDN1, JUNB 12.94 8.86E-08 
 
Note. Different genes are regulated in human versus mouse model. 
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Figure 12. TNF signaling pathway  
Note. TNF signaling pathway as membranous receptor (TNFR1 or TNFR2) interacts with TNF signal. A series of reactions inside the 
cell are demonstrated, leading to cell death. This is a concise figure. More proteins and chemical compounds can be involved in this 
pathway. 
TNF 
TNFR1 FADD Caspase-8 
Apoptosis 
TNF TNFR2 
TRADD 
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Chapter 6: Conclusion   
In summary, gene number is related to cell survival in human aortic endothelial 
cells cultured with different materials, shapes, and functional group. Small sized silica 
nanoparticles are more toxic in medium concentration in mouse macrophages and lung 
cancer cells. Tumor necrosis factor signaling pathway is the main pathway involved in 
the toxicity mechanism of silica nanoparticles no matter what the size, the shape of the 
silica NPs is, or no matter what kind of the cells is. 
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Appendix 
Abbreviation list 
COOH: carboxyl 
DAVID: Database for Annotation, Visualization and Integrated Discovery 
GEO: Gene Expression Omnibus 
HAECs: human aortic endothelial cells 
HBV: hepatitis B virus 
HCC: hepatocellular carcinoma  
MSNPs: mesoporous silica nanoparticles 
NCBI: National Center for Biotechnology Information 
NH2: amine 
NPs: nanoparticles 
PAMAM: poly-amido-amine 
SiO2: silicon dioxide 
SNPs: silica nanoparticles 
TiO2: titanium dioxide 
TiO2-NB: nanobelts 
TNF: tumor necrosis factor  
UV: ultraviolet  
  
